Reprints
PubMed
CAVEAT LECTOR
RAS PATHWAYS TO CELL CYCLE CONTROL AND CELL TRANSFORMATION
Marcos Malumbres and Angel Pellicer
Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, 550 First Avenue, New York
Received 7/17/98 Accepted 7/25/98
9. REFERENCES
1. Harvey J. J.: An unidentified virus which causes the rapid production of tumors in mice. Nature 204, 1104-1105 (1964)
2. Kirsten W. H. & L. A. Mayer: Morphologic responses to a murine erythroblastosis virus. J Natl Cancer Inst 39, 311-335 (1967)
3. Shih T. Y., M. O. Weeks, H. A. Young & E. M. Scolnick: Identification of sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirstein or Harvey murine sarcoma virus. Virology 96, 64-79 (1979)
4. Tabin C. J., S. M. Bradley, C. I. Bargmenn, R. A. Weinberg, A. G. Papageorge, E. M. Scolnick, R. Dhar, D. R. Lowy & E. H. Chang: Mechanism of activation of a human oncogene. Nature 300, 143-147 (1982)
5. Reddy E. P., R. K. Reynolds, E. Santos & M. Barbacid: A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300, 149-152 (1982)
6. Barbacid M.: ras genes. Ann Rev Biochem 56, 779-827 (1987)
7. Lowy D. R. & B. M. Willumsen: Function and regulation of ras. Ann Rev Biochem 62, 851-891 (1993)
8. Downward J.: Ras signalling and apoptosis. Curr Opin Genet Dev 8, 49-54 (1998)
9. Khosravi-Far R., S. Campbell, K. L. Rossman & C. J. Der: Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv Cancer Res 72, 57-107 (1998)
10. Bos J. L.: ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689 (1989)
11. Rodenhuis S.: ras and human tumors. Semin Cancer Biol 3, 241-247 (1992)
12. León J. & A. Pellicer: ras genes involvement in carcinogenesis: lessons from animal model systems. In: The ras superfamily of GTPases (J.C. Lacal & F. McCormick), CRC Press, Boca Raton, pp. 3-36 (1993)
13. Mangues R. & A. Pellicer: Ras activation in experimental carcinogenesis. Semin Cancer Biol 3, 229-239 (1992)
14. Bourne H. R., D. A. Sanders & F. McCormick: The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348, 125-132 (1990)
15. Bos J. L.: Ras-like GTPases. Biochim Biophys Acta 1333, M19-31 (1997)
16. Kimmelman A., T. Tolkacheva, M. V. Lorenzi, M. Osada & A. M.-L. Chan: Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution. Oncogene 15, 2675-2685 (1997)
17. Matsumoto K., T. Asano & T. Endo: Novel small GTPase M-Ras participates in reorganization of actin cytoskeleton. Oncogene 15, 2409-2417 (1997)
18. Graham S. M., A. D. Cox, G. Drivas, M. G. Rush, P. D'Eustachio & C. J. Der: Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol Cell Biol 14, 4108-4115 (1994)
19. Chan A. M. L., T. Miki, K. A. Meyers & S. A. Aaronson: A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. Proc Natl Acad Sci USA 91, 7558-7562 (1994)
20. Saez R., A. M. L. Chan, T. Miki & S. A. Aaronson: Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes. Oncogene 9, 2977-2982 (1994)
21. Cox A. D., T. R. Brtva, D. G. Lowe & C. J. Der: R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene 9, 3281-3288 (1994)
22. Huang Y, R. Saez, L. Chao, E. Santos, S. A. Aaronson & A. M. L. Chan: A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene 11, 1255-1260 (1995)
23. Kitayama H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa & M. Noda: A ras-related gene with transformation suppressor activity. Cell 56, 77-84 (1989)
24. Altschuler D. L. & F. Ribeiro-Neto: Mitogenic and oncogenic properties of the small G protein Rap1b. Proc Natl Acad Sci USA 95, 7475-7479 (1998)
25. Paciucci R. & A. Pellicer: Dissection of the mouse N-ras gene upstream regulatory sequences, overlapping with an adjacent gene. Mol Cell Biol 11, 1334-1343 (1991)
26. Jeffers M. & A. Pellicer: Identification of multiple promoters within the N-ras proto-oncogene. Biochem Biophys Acta 1219, 623-635 (1994)
27. Cohen J. B., S. D. Broz & A. D. Levinson: Expression of the H-ras proto-oncogene is controlled by alternative splicing. Cell 58, 461-472 (1989)
28. Huang M. Y. & J. B. Cohen: The alternative H-ras protein p19 displays properties of a negative regulator of p21Ras. Oncol Res 9, 611-621 (1997)
29. León J., I. Guerrero & A. Pellicer: Different expression of the ras gene family in mice. Mol Cell Biol 7, 1535-1540 (1987)
30. Furth M. E., T. H. Aldrich & C. Cordon-Cardo: Expression of ras proto-oncogene proteins in normal human tissues. Oncogene 1, 47-58 (1987)
31. Pells S., M. Divjak, P. Romanowski, K. Impey, N. J. Hawkins, A. R. Clarke, M. L. Hooper & D. J. Williamson: Developmentally-regulated expression of murine K-ras isoforms. Oncogene 15, 1781-1786 (1997)
32. Scheele J. S., J. M. Rhee & G. R. Boss: Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: comparison of parental and Ras-overproducing NIH 3T3 fibroblasts. Proc Natl Acad Sci USA 92, 1097-1100 (1995)
33. Quincoces A. F. & J. Leon: Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts. Cell Growth Differ 6, 271-279 (1995)
34. Quincoces A. F., I. Polanco, T. Thomson & J. Leon: Positive autoregulation of ras genes expression in fibroblasts. FEBS Lett 416, 317-323 (1997)
35. Boussadia O., F. Amiot, S. Cases, G. Triqueneaux, H. Jacquemin-Sablon & F. Dautry: Transcription of unr (upstream of N-ras) down-modulates N-ras expression In vivo. FEBS Lett 420, 20-24 (1997)
36. Ulsh L. & T. Y. Shih: Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol Cell Biol 4, 1647-1652 (1984)
37. Willumsen B. M., A. Christensen, N. L. Hubbert, A. G. Papageorge & D. R. Lowy: The p21 ras C-terminus is required for transformation and membrane association. Nature 310, 583-586 (1984)
38. Lacal P. M., C. Y. Pennington & J. C. Lacal: Transforming activity of ras proteins translocated to the plasma membrane by a myristoylation sequence from the src gene product. Oncogene 2, 533-537 (1988)
39. Buss J. E., P. A. Solski, J. P. Schaeffer, M. J. MacDonald & C. J. Der: Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal. Science 243, 1600-1603 (1989)
40. Denhardt D. T.: Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 318, 729-747 (1996)
41. Krengel U., L. Schlichting, A. Scherer, R. Schumann, M. Frech, J. John, W. Kabsch, E. F. Pai & A. Wittinghofer: Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell 62, 539-548 (1990)
42. Bollag G. & F. McCormick: Regulators and effectors of ras proteins. Ann Rev Cell Biol 7, 601-632 (1991)
43. Boguski M. S. & F. McCormick: Proteins regulating Ras and its relatives. Nature 366, 643-654 (1993)
44. Scheffzek K., M. R. Ahmadian, W. Kabsch, L. Wiesmüller, A. Lautwein, F. Schmitz & A. Wittinghofer: The Ras-RasGAP complex: structural basis for GTPase activation and itss loss in oncogenic Ras mutants. Science 277, 333-338 (1997)
45. Wittinghofer A. & E. Pai: The structure of Ras protein: a model for a universal molecular switch. Trends Biochem Sci 16, 382-387 (1991)
46. Ma J. & M. Karplus: Molecular switch in signal transduction: reaction paths of the conformational changes in ras p21. Proc Natl Acad Sci USA 94, 11905-11910 (1997)
47. Kinzler K. W. & B. Vogelstein: Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996)
48. Mangues R., I. Seidman, J. W. Gordon & A. Pellicer: Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. Oncogene 7, 2073-2076 (1992)
49. Hua V. Y., W. K. Wang & P. H. Duesberg: Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers. Proc Natl Acad Sci USA 94, 9614-9619 (1997)
50. Brandt-Rauf P. W., R. P. Carty, J. Chen, M. Avitable, J. Lubowsky & M. R. Pincus: Structure of the carboxyl terminus of the RAS gene-encoded P21 proteins. Proc. Natl. Acad. Sci. USA 85, 5869-5873 (1988)
51. Ballester R., M. E. Furth & O. M. Rosen: Phorbol ester- and protein kinase C-mediated phosphorylation of the cellular Kirsten ras gene product. J Biol Chem 262, 2688-2695 (1987)
52. Mellersh H., A. J. Strain & D. J. Hill: Expression of the proto-oncogenes c-H-ras and N-ras in early second trimester human fetal tissues. Biochem Biophys Res Commun 141, 510-6 (1986)
53. Tanaka T., N. Ida, H. Shimoda, C. Waki, D. J. Slamon & M. J. Cline: Organ specific expression of ras oncoproteins during growth and development of the rat. Mol Cell Biochem 70, 97-104 (1986)
54. Fiorucci G. & A. Hall: All three human ras genes are expressed in a wide range of tissues. Biochem. Biophys. Acta 950, 81-83 (1988)
55. Muller R., D. J. Slamon, E. D. Adamson, J. M. Tremblay, D. Muller, M. J. Cline & I. M. Verma: Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol 3, 1062-1069 (1983)
56. Delgado M. D., A. F. Quincoces, M. T. Gomez-Casares, C. A. Martinez, M. A. Cuadrado, C. Richard & J. Leon: Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells. Cancer Res 52, 5979-84 (1992)
57. James G. L., J. L. Goldstein & M. S. Brown: Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J Biol Chem 270, 6221-6226 (1995)
58. Grand R. J. A. & D. Owen: The biochemistry of ras p21. Biochem J 279, 609-631 (1991)
59. Lerner E. C., T. T. Zhang, D. B. Knowles, Y. Qian, A. D. Hamilton & S. M. Sebti: Inhibition of the prenylation of K-Ras, nut not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines. Oncogene 15, 1283-1288 (1997)
60. Mangues R., T. Corral, N. E. Kohl, W. F. Symmans, S. Lu, M. Malumbres, J. B. Gibbs, A. Oliff & A. Pellicer: Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice. Cancer Res 58, 1253-1259 (1998)
61. Carbone A., G. L. Gusella, D. Radzioch & L. Varesio: Human Harvey-ras is biochemically different from Kirsten- or N-ras. Oncogene 6, 731-737 (1991)
62. Bollag G. & F. McCormick: Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 351, 576-579 (1991)
63. Mizuno T., K. Kaibuchi, T. Yamamoto, M. Kawamura, T. Sakoda, H. Fujioka, Y. Matsuura & Y. Takai: A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 and rhoA p21. Proc. Natl. Acad. Sci. USA 88, 6442-6446 (1991)
64. Jones M. K. & J. H. Jackson: Ras-GRF activates Ha-Ras, but not N-Ras or K-Ras 4B, protein In vivo. J Biol Chem 273, 1782-1787 (1998)
65. Francis-Lang H., M. Zannini, M. De Felice, M. T. Berlingieri, A. Fusco & R. Di Lauro: Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol Cell Biol 12, 5793-5800 (1992)
66. Maher J., D. Baker, M. Manning, N. J. Dibb & I. A. G. Roberts: Evidence for cell-specific differences in transformation by N-, H- and K-ras. Oncogene 11, 1639-1647 (1995)
67. Skorski T., C. Szczylik, M. Z. Ratajczak, L. Malaguarnera, A. M. Gewirtz & B. Calabretta: Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides. J Exp Med 175, 743-750 (1992)
68. Chen G., S. Oh, B. P. Monia & D. W. Stacey: Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts. J Biol Chem 271, 28259-28265 (1996)
69. Billadeau D., P. Liu, D. Jelinek, N. Shah, T. W. LeBien & B. Van Ness: Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6. Cancer Res. 57, 2268-2275 (1997)
70. Yan Z., M. Chen, M. Perucho & E. Friedman: Oncogenic Ki-ras but not oncogenic Ha-ras blocks integrin b1-chain maduration in colon epithelial cells. J Biol Chem 272, 30928-30936 (1997)
71. Yan Z., X. Deng, M. Chen, Y. Xu, M. Ahram, B. F. Sloane & E. Friedman: Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells. J Biol Chem 272, 27902-27907 (1997)
72. Umanoff H., W. Edelmann, A. Pellicer & R. Kucherlapati: The murine N-ras gene is not essential for development. Proc Natl Acad Sci USA 92, 1709-1713 (1995)
73. Koera K., K. Nakamura, K. Nakao, J. Miyoshi, K. Toyoshima, T. Hatta, H. Otani, A. Aiba & M. Katsui: K-Ras is essential for the development of the mouse embryo. Oncogene 15, 1151-1159 (1997)
74. Johnson L., D. Greenbaum, K. Cichowski, K. Mercer, E. Murphy, E. Schmitt, R. T. Bronson, H. Umanoff, W. Edelmann, R. Kucherlapati & T. Jacks: K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11, 2468-81 (1997)
75. Hamilton M. & A. Wolfman: Ha-ras and N-ras regulate MAPK activity by distinct mechanisms In vivo. Oncogene 16, 1417-1428 (1998)
76. Pawson T.: Protein modules and signalling networks. Nature 373, 573-580 (1995)
77. Bonfini L., E. Migliaccio, G. Pellici, L. Lanfrancone & P. G. Pelicci: Not all Shc's roads lead to Ras. Trends Biochem Sci 21, 257-261 (1996)
78. Lopez-Ilasaca M., P. Crespo, P. G. Pellici, J. S. Gutkind & R. Wetzker: Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase g. Science 275, 394-397 (1997)
79. Crespo P., N. Xu, W. F. Symonds & J. S. Gutkind: Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 369, 418-420 (1994)
80. Feig L. A. & G. M. Cooper: Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with a preferential affinity for GDP. Mol Cell Biol 8, 3235-3243 (1988)
81. El-Shemerly M. Y. M., D. Besser, M. Nagasawa & Y. Nagamine: 12-O-tetradecanoylphorbol-13-acetate activates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway upstream of Sos involving serine phosphorylation of Shc in NIH3T3 cells. J Biol Chem 272, 30599-30602 (1997)
82. Marais R., Y. Light, C. Mason, H. Paterson, M. F. Olson & C. J. Marshall: Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280, 109-112 (1998)
83. Bourne H. R., D. A. Sanders & F. McCormick: The GTPase superfamily: conserved structure and molecular mechanism. Nature 349, 117-126 (1991)
84. Quilliam L. A., R. Khosravi-Far, S. Y. Huff & C. J. Der: Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins. Bioassays 17, 395-404 (1995)
85. Fam N. P., W.-T. Fan, Z. Wang, L.-J. Zhang, H. Chen & M. F. Moran: Cloning and characterization of Ras-GRF2, a novel guanine nucleotide exchange factor for Ras. Mol Cell Biol 17, 1396-1406 (1997)
86. Ebinu J. O., D. A. Bottorff, E. Y. W. Chan, S. L. Stang, R. J. Dunn & J. C. Stone: RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Science 280, 1082-1086 (1998)
87. Egan S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland & R. A. Weinberg: Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363, 45-51 (1993)
88. Farnsworth C. L., N. W. Freshney, L. B. Rosen, A. Ghosh, M. E. Greenberg & L. A. Feig: Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 376, 524-527 (1995)
89. Gotoh T., Y. Niino, M. Tokuda, O. Hatase, S. Nakamura, M. Matsuda & S. Hattori: Activation of R-Ras by Ras-guanine nucleotide-releasing factor. J Biol Chem 272, 18602-18607 (1997)
90. Bowtell D., P. Fu, M. Simon & P. Senior: Identification of murine homologues of the Drosophila Son of sevenless gene: potential activators of ras. Proc Natl Acad Sci USA 89, 6511-6515 (1992)
91. Bonfini L., C.A. Karlovich, C. Dasgupta & U. Banerjee: The Son of sevenless gene product: a putative activator of ras. Science 255, 603-606 (1992)
92. Shou C., C. L. Farnsworth, B. G. Neel & L. A. Feig: Molecular cloning of cDNA encoding a guanine-nucleotide-releasing factor for Ras p21. Nature 358, 351-354 (1992)
93. Lowenstein E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi & J. Schlessinger: The SH2 and the SH3 domain-cointaining protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70, 431-442 (1992)
94. Rozakis-Adcock M., J. McGlade, G. Mbamalu, G. Pellicci, R. Daly, A. Batzer, S. Thomas, J. Brugge, P. G. Pelici, J. Schlessinger & T. Pawson: Association of the SHC and GRB2/Sem5 SH2-containing proteins is implicated in activation of the ras pathway by tyrosine kinases. Nature 360, 689-692 (1992)
95. Gale N. W., S. Kaplan, E. J. Lowenstein, J. Schelessinger & D. Bar-Sagi: Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on ras. Nature 363, 88-92 (1993)
96. Chardin P., J. H. Camonis, N. W. Gale, L. Van Aelst, J. Schlessinger, M. H. Wigler & D. Bar-Sagi: Human Sos1: a guanine nucleotide exchange factor for ras that binds to GRB2. Science 260, 1338-1343 (1993)
97. Schlessinger J.: How receptor tyrosine kinases activate Ras. Trends Biochem Sci 18, 273-275 (1993)
98. Kim J. H., M. Shirouzu, T. Kataoka, D. Bowtell & S. Yokoyama: Activation of Ras and its downstream extracellular signal-regulated protein kinases by the CDC25 homology domain of mouse Son-of-sevenless 1 (mSos1). Oncogene 16, 2597-2607 (1998)
99. Nimnual A. S., B. A. Yatsula & D. Bar-Sagi: Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 279, 560-563 (1998)
100. Jefferson A. B., A. Klippel & L. T. Williams: Inhibition of mSOS-activity by binding of phosphatidylinositol 4,5-P2 to the mSOS pleckstrin homology domain. Oncogene 16, 2303-2310 (1998)
101. Martegani E., M. Vanoni, R. Zippel, P. Coccetti, R. Brambilla, C. Farrari, E. Sturani & L. Alberghina: Cloning by functional complementation of a mouse cDNA encoding a homolog of CDC25, a Saccharomyces cervisiae Ras activator. EMBO J 11, 2151-2157 (1992)
102. Wei W., R. D. Mosteller, P. Sanyal, E. Gonzales, D. McKinney, C. Dagupta, P. Li, B.-X. Liu & D. Broek: Identification of a mammalian gene structurally and functionally related to the CD25 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 89, 7100-7104 (1992)
103. Guerrero C., J. M. Rojas, M. Chedid, L. M. Esteban, D. B. Zimonjic, N. C. Popescu, J. Font de Mora & E. Santos: Expression of alternative forms of Ras exchange factors GRF and SOS1 in different human tissues and cell lines. Oncogene 12, 1097-1107 (1996)
104. Whitehead I. P., S. Campbell, K. L. Rossman & C. J. Der: Dbl family proteins. Biochim Biophys Acta 1332, F1-23 (1997)
105. Bustelo X. R., K. R. Suen, K. Leftheris, C. A. Meyers & M. Barbacid: Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 9, 2405-2413 (1994)
106. Khosravi-Far R., M. Chrzanowska-Wodnicka, P. A. Solski, A. Eva, K. Burridge & C. J. Der: Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol 14, 6848-6857 (1994)
107. Han J., B. Das, W. Wei, L. Van Aelst, R. D. Mosteller, R. Khosravi-Far, J. K. Westwick, C. J. Der & D. Broek: Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol 17, 1346-1353 (1997)
108. Crespo P., K. E. Schuebel, A. A. Ostrom, J. S. Gutkind & X. R. Bustelo: Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385, 169-172 (1997)
109. Han J., K. Luby-Phelps, B. Das, X. Shu, Y. Xia, R. D. Mosteller, U. M. Krishna, J. R. Falck, M. A. White & D. Broek: Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279, 558-560 (1998)
110. Trahey M. & F. McCormick: A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238, 542-545 (1987)
111. Gibbs J. B., M. D. Schaber, W. J. Allard, I. S. Sigal & E. M. Scolnick: Purification of ras GTPase activating protein from bovine brain. Proc Natl Acad Sci USA 85, 5026-5030 (1988)
112. Martin G. A., D. Viskochil, G. Bollag, P. C. McCabe & W. J. Crosier: The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63, 843-849 (1990)
113. Ballester R., D. Marchuck, M. Boguski, A. Saulino, R. Letcher, M. Wigler & F. Collins: The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851-859 (1990)
114. Maekawa M., S. Li, A. Iwamatsu, T. Morishita, K. Yokota, Y. Imai, S. Kohsaka, S. Nakamura & S. Hattori: A novel mammalian Ras GTPase-activating protein which has phospholipid-binding and Btk homology regions. Mol Cell Biol 14, 6879-6885 (1994)
115. Weissbach L., J. Settleman, M. F. Kalady, A. J. Snijders, A. E. Murthy, Y. X. Yan & A. Bernards: Identification of a human rasGAP-related protein containing calmodulin-binding motifs. J Biol Chem 269, 20517-20521 (1994)
116. Tocque B., I. Delumeau, F. Parker, F. Maurier, M. C. Multon & F. Schweighoffer: Ras-GTPase activating protein (GAP): a putative effector for Ras. Cell Signal 9, 153-158 (1997)
117. Kim J. H., D. Liao, L. F. Lau & R. L. Huganir: SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20, 683-691 (1998)
118. Chen H. J., M. Rojas-Soto, A. Oguni & M. B. Kennedy: A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 20, 895-904 (1998)
119. Zhang K., J. E. DeClue, W. Vass, A. G. Papageorge, F. McCormick & D. R. Lowy: Suppression of c-ras transformation by GTPase-activating protein. Nature 346, 754-756 (1990)
120. Marshall M. S.: Ras target proteins in eukaryotic cells. FASEB J 9, 1311-1318 (1995)
121. Katz M. E. & F. McCormick: Signal transduction from multiple Ras effectors. Curr Opin Genet Dev 7, 75-79 (1997)
122. Polakis P. & F. McCormick: Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target. J Biol Chem 268, 9157-9160 (1993)
123. Moodie S. A., M. Paris, E. Villafranca, P. Kirshmeier, B. M. Willumsen & A. Wolfman: Different structural requirements within the switch II region of the Ras protein for interaction with specific downstream targets. Oncogene 11, 447-54 (1995)
124. Fujita-Yoshigaki J., M. Shirouzu, Y. Ito, S. Hattori, S. Furuyama, S. Nishimura & S. Yokoyama: A constitutive effector region on the C-terminal side of switch I of the Ras protein. J Biol Chem 270, 4661-4667 (1995)
125. Wittinghofer A. & N. Nassar: How Ras-related proteins talk to their effectors. Trends Biochem Sci 21, 488-491 (1996)
126. Sprang S. R.: G proteins, effectors and GAPs: structure and mechanism. Curr Opin Struct Biol 7, 849-856 (1997)
127. Geyer M. & A. Wittinghofer: GEFs, GAPs, GDIs and effectors: taking a closer (3D) look at the regulation of Ras-related GTP-binding proteins. Curr Opin Struct Biol 7, 786-792 (1997)
128. Marshall M. S.: The effector interactions of p21ras. Trends Biochem Sci 18, 250-254 (1993)
129. White M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin & M. H. Wigler: Multiple Ras functions can contribute to mammalian cell transformation. Cell 80, 533-541 (1995)
130. Akasaka K., M. Tamada, F. Wang, K. Kariya, F. Shima, A. Kikuchi, M. Yamamoto, M. Shirouzu, S. Yokoyama & T. Kataoka: Differential structural requirements for interaction of Ras protein with its distinct downstream effectors. J Biol Chem 271, 5353-5360 (1996)
131. Rodriguez-Viciana P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley & J. Downward: Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89, 457-467 (1997)
132. Moodie S. A., B. M. Willumsen, M. J. Weber & A. Wolfman: Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260, 1658-1661 (1993)
133. Vojitek A. B., S. M. Hollenbarg & J. A. Cooper: Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74, 205-214 (1993)
134. Warne P. H., P. Rodriguez-Viciana & J. Downward: Direct interaction of Ras and the amino-terminal region of Raf-1 In vitro. Nature 364, 352-355 (1993)
135. Zhang X. F., J. Settleman, J. M. Kyriakis, E. Takeuchi-Suzuki, S. J. Elledge, M. S. Marshall, J. T. Bruder, U. R. Rapp & J. Avruch: Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364, 308-313 (1993)
136. Stokoe D., S. G. Mcdonald, K. Cadwallader, M. Symmons & J. F. Hancock: Activation of Raf as a result of recruitment to the plasma membrane. Science 264, 1463-1467 (1994)
137. Kyriakis J. M., H. App, X. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp & J. Avruch: Raf-1 activates MAP kinase-kinase. Nature 358, 417-421 (1992)
138. Cowley S., H. Paterson, P. Kemp & C. J. Marshall: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852 (1994)
139. Ahn N. G., R. Seger, R. L. Bratlien, C. D. Diltz, N. K. Tonks & E. G. Krebs: Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule associated protein 2 kinase. J Biol Chem 266, 4220-4227 (1991)
140. Gómez N. & P. Cohen: Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 351, 69-72 (1991)
141. Kosako H., Y. Gotoh, S. Matsuda, M. Ishikawa & E. Nishida: Xenopus MAP kinase activator is a serine/threonine/tyrosine kinase activated by threonine phosphorylation. EMBO J 11, 2903-2908 (1992)
142. Nakielny S., P. Cohen, J. Wu & T. W. Sturgill: MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J 11, 2123-2129 (1992)
143. Khokhlatchev A. V., B. Canagarajah, J. Wilsbacher, M. Robinson, M. Atkinson, E. Goldsmith & M. H. Cobb: Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93, 605-615 (1998)
144. Gille H., A. D. Sharrocks & P. E. Shaw: Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358, 414-417 (1992)
145. Marshall C. J.: MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4, 82-89 (1994)
146. Treisman R.: Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8, 205-215 (1996)
147. Xing J., D. D. Ginty & M. E. Greenberg: Coupling of the Ras-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273, 959-963 (1996)
148. Mansour S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude & N. G. Ahn: Transformation of mammalian cells by constituvely active MAP kinase kinase. Science 265, 966-970 (1994)
149. Kerkhoff E. & U. R. Rapp: Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol Cell Biol 17, 2576-2586 (1997)
150. Falasca M., C. Iurisci, A. Carvelli, A. Sacchetti & D. Corda: Release of the mitogen lysophosphatidylinositol from H-Ras-transformed fibroblasts; a possible mechanism of autocrine control of cell proliferation. Oncogene 16, 2357-2365 (1998)
151. Marais R., Y. Light, H. F. Paterson, C. S. Mason & C. J. Marshall: Differential regulation of Raf-1, A-Raf, and B.Raf by oncogenic Ras and tyrosine kinases. J Biol Chem 272, 4378-4383 (1997)
152. Leevers S. J., H. F. Paterson & C. J. Marshall: Requirement for Ras in Raf activation is overcome by targeting raf to the plasma membrane. Nature 369, 411-414 (1994)
153. Yamamori B., S. Kuroda, K. Shimizu, K. Fukui, T. Ohtsuka & Y. Takai: Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. J Biol Chem 270, 11723-11726 (1995)
154. Patriotis C., A. Makris, J. Chernoff & P. N. Tsichlis: Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc Natl Acad Sci USA 91, 9755-9759 (1994)
155. Salmeron A., T. B. Ahmad, G. W. Carlile, D. Pappin, R. P. Narsimhan & S. C. Ley: Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J 15, 817-826 (1996)
156. Hunter T.: Oncoprotein networks. Cell 88, 333-346 (1997)
157. Morrison D.: 14-3-3: modulators of signaling proteins? Science 266, 56-57 (1994)
158. Roy S., R. A. McPherson, A. Apolloni, J. Yan, A. Lane, J. Clyde-Smith & J. F. Hancock: 14-3-3 facilitates Ras-dependent Raf-1 activation In vitro and In vivo. Mol Cell Biol 18, 3947-3955 (1998)
159. Joneson T., J. A. Fulton, D. J. Volle, O. V. Chaika, D. Bar-Sagi & R. E. Lewis: Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras and Ras effectors. J Biol Chem 273, 7743-7748 (1998)
160. Denouel-Galy A., E. M. Douville, P. H. Warne, C. Papin, D. Laugier, G. Calothy, J. Downward & A. Eychene: Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr Biol 8, 46-55 (1998)
161. Yu W., W. J. Fantl, G. Harrowe & L. T. Williams: Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr Biol 8, 56-64 (1998)
162. Sugimoto T., S. Stewart, M. Han & K. L. Guan: The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation. EMBO J 17, 1717-1727 (1998)
163. Hofer F., S. Fields, C. Schneider & G. S. Martin: Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA 91, 11089-11093 (1994)
164. Kikuchi A., S. D. Demo, Z. H. Ye, Y. W. Chen & L. T. Williams: ralGDS family members interact with the effector loop of ras p21. Mol Cell Biol 14, 7483-7491 (1994)
165. Spaargaren M. & J. R. Bischoff: Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc Natl Acad Sci USA 91, 12609-12613 (1994)
166. Feig L. A., T. Urano & S. Cantor: Evidence for a Ras/Ral signaling cascade. Trends Biochem Sci 21, 438-441 (1996)
167. Peterson S. N., L. Trabalzini, T. R. Brtva, T. Fischer, D. L. Altschuler, P. Martelli, E. G. Lapetina, C. J. Der & G. C. White 2nd: Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1. J Biol Chem 271, 29903-29908 (1996)
168. Wolthuis R. M. F., B. Bauer, L. J. van’t Veer, A. M. M. de Vries-Smits, R. H. Cool, M. Spaargaren, A. Wittinghofer, B. M. T. Burgering & J. L. Bos: RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene 12, 353-362 (1996)
169. Kikuchi A. & L. T. Williams: Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase. J Biol Chem 271, 588-594 (1996)
170. Miller M. J., S. Prigent, E. Kupperman, L. Rioux, S. H. Park, J. R. Feramisco, M. A. White, J. L. Rutkowski & J. L. Meinkoth: RalGDS functions in Ras- and cAMP-mediated growth stimulation. J Biol Chem 272, 5600-5605 (1997)
171. Urano T., R. Emkey & L. A. Feig: Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J 15, 810-816 (1996)
172. Wolthuis R. M., F. Zwartkruis, T. C. Moen & J. L. Bos: Ras-dependent activation of the small GTPase Ral. Curr Biol 8, 471-474 (1998)
173. Kishida S., S. Koyama, K. Matsubara, M. Kishida, Y. Matsuura & A. Kikuchi: Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator. Oncogene 15, 2899-2907 (1997)
174. White M. A., T. Vale, J. H. Camonis, E. Schaefer & M. H. Wigler: A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J Biol Chem 271, 16439-16442 (1996)
175. Huang L., F. Hofer, G. S. Martin & S. H. Kim: Structural basis for the interaction of Ras with RalGDS. Nat Struct Biol 5, 422-426 (1998)
176. Cantor S. B., T. Urano & L. A. Feig: Identification and characterization of Ral-binding protein 1, a potential donwstream target of Ral GTPases. Mol Cell Biol 15, 4578-4584 (1995)
177. Jullien-Flores V., O. Dorseuil, F. Romero, F. Letourneur, S. Saragosti, R. Berger, A. Tavitian, G. Gacon & J. H. Camonis: Bridging Ral GTPase to Rho pathways. J Biol Chem 270, 22473-22477 (1995)
178. Park S. H. & R. A. Weinberg: A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 11, 2349-2355 (1995)
179. Yamaguchi A., T. Urano, T. Goi & L. A. Feig: An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1. J Biol Chem 272, 31230-31234 (1997)
180. Jiang H., J. Q. Luo, T. Urano, P. Frankel, Z. Lu, D. A. Foster & L. A. Feig: Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 378, 409-412 (1995)
181. Luo J. Q., X. Liu, P. Frankel, T. Rotunda, M. Ramos, J. Flom, H. Jiang, L. A. Feig, A. J. Morris, R. A. Kahn & D. A. Foster: Functional association between arf and RalA in active phospholipase D complex. Proc Natl Acad Sci USA 95, 3632-3637 (1998)
182. D'Adamo D. R., S. Novick, J. M. Kahn, P. Leonardi & A. Pellicer: rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral. Oncogene 14, 1295-1305 (1997)
183. Okazaki M., S. Kishida, T. Hinoi, T. Hasegawa, M. Tamada, T. Kataoka & A. Kikuchi: Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator. Oncogene 14, 515-521 (1997)
184. Rodriguez-Viciana P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield & J. Downward: Phosphatidylinositol-3-OH Kinase as a direct target for ras. Nature 370, 527-532 (1994)
185. RodrÌguez-Viciana P., P. H. Warne, M. D. Waterfield & J. Downward: Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J 15, 2242-2251 (1996)
186. Downward J.: Lipid-regulated kinases: some common themes at last. Science 279, 673-674 (1998)
187. Dudek H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan & M. E. Greenberg: Regulation of neuronal survival by the serine-threonine prtoein kinase Akt. Science 275, 661-665 (1997)
188. Kauffman-Zeh A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward & G. Evan: Suppression of c-myc-induced apoptosis by Ras signaling through PI(3)K and PKB. Nature 385, 544-548 (1997)
189. Berra E., M. T. Diaz-Meco & J. Moscat: The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273, 10792-10797 (1998)
190. Hu Q., A. Klippel, A. J. Mulsin, W. J. Fantl & L. T. Williams: Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268, 100-102 (1995)
191. McIlroy J., D. Chen, C. Wjasow, T. Michaeli & J. M. Backer: Specific activation of p85-p110 phosphatidylinosotol 3'-kinase stimulates DNA synthesis by ras- and p70 S6 kinase-dependent pathways. Mol Cell Biol 17, 248-255 (1997)
192. Weering D. H. van, J. de Rooij, B. Marte, J. Downward, J. L. Bos & B. M. Burgering: Protein kinase B activation and lemallipodium formation are independent phosphoinositide 3-kinase-mediated events differentially regulated by endogenous Ras. Mol Cell Biol 18, 1802-1811 (1998)
193. Hawkins P. T., A. Eguinoa, R. G. Qui, D. Stokoe, F. T. Cooke, R. Walters, S. Wennstrom, L. Claesson-Welsh, T. Evans, M. Symons & L. Stephens: PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-Kinase. Curr Biol 5, 393-403 (1995)
194. Hall A.: Rho GTPases and the actin cytoskeleton. Science 279, 509-514 (1998)
195. Olson M. F.. A. Ashworth & A. Hall: An essential role for Rho, Rac and Cdc42 GTPases in cell cycle progression through G1. Science 269, 1270-1272 (1995)
196. Coso O. A., M. Chiariello, J.-C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki & J. S. Gutkind: The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81, 1137-1146 (1995)
197. Minden A., A. Lin, F.-X. Claret, A. Abo & M. Karin: Selective activation of the JNK signaling cascade and c-jun transcriptional activity by the samll GTPases Rac and Cdc42Hs. Cell 81, 1147-1157 (1995)
198. Hill C. S., J. Wynne & R. Treisman: The Rho family GTPases RhoA, Rac1 and Cdc42Hs regulate transcriptional activation by SRF. Cell 81, 1159-1170 (1995)
199. Khosravi-Far R., P. A. Solski, G. J. Clark, M. S. Kinch & C. J. Der: Activation of Rac1, RhoA, and mitogen-activated protien kinases is required for Ras transformation. Mol Cell Biol 15, 6443-6453 (1995)
200. Prendergast G. C., R. Khosravi-Far, P. A. Solski, H. Kurzawa, P. F. Lebowitz & C. J. Der: Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10, 2289-2296 (1995)
201. Qiu R. G., J. Chen, F. McCormick & M. Symons: A role for Rho in Ras transformation. Proc Natl Acad Sci USA 92, 6443-6453 (1995)
202. Qiu R. G., J. Chen, D. Kirn, F. McCormick & M. Symons: An essential role for Ras in Ras transformation. Nature 374, 457-459 (1995)
203. Roux P., C. Gauthier-Rouviere, S. Doucet-Brutin & P. Fort: The small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-independent pathways that cooperate to transform NIH3T3 cells. Curr Biol 7, 629-637 (1997)
204. Joneson T., M. A. White, M. H. Wigler & D. Bar-Sagi: Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271, 810-812 (1996)
205. Chant J. & L. Stowers: GTPase cascades choreographing cellular behavior: movement, morphogenesis, and more. Cell 81, 1-4 (1995)
206. Auer K. L., J. Contessa, S. Brenz-Verca, L. Pirola, S. Rusconi, G. Cooper, A. Abo, M. P. Wymann, R. J. Davis, M. Birrer & P. Dent: The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol Biol Cell 9, 561-573 (1998)
207. Horii Y., J. F. Beeler, K. Sakaguchi, M. Tachibana & T. Miki: A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. EMBO J 13, 4776-4786 (1994)
208. Van Aelst L. & C. D'Souza-Schorey: Rho GTPases and signaling networks. Genes Dev 11, 2295-2322 (1997)
209. Tang Y., Z. Chen, D. ambrose, J. Liu, J. B. Gibbs, J. Chernoff & J. Field: Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts. Mol Cell Biol 17, 4454-4464 (1997)
210. Tapon N., K. Nagata, N. Lamarche & A. Hall: A new Rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kB signalling pathways. EMBO J 17, 1395-1404 (1998)
211. Freeman J. L., A. Abo & J. D. Lambeth: Rac 'insert region' is a novel effector region that is implicated in the activation of NADPH oxidase, but not PAK65. J Biol Chem 271, 19794-19801 (1996)
212. Joneson T., M. McDonough, D. Bar-Sagi & L. Van Aelst: RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase. Science 274, 1374-1376 (1996)
213. Lamarche N., N. Tapon, L. Stowers, P. D. Burbelo, P. Aspenstrom, T. Bridges, J. Chant & A. Hall: Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 87, 519-529 (1996)
214. Westwick J. K., Q. T. Lambert, G. J. Clark, M. Symons, L. Van Aelst, R. G. Pestell & C. J. Der: Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol Cell Biol 17, 1324-1335 (1997)
215. Sahai E., A. S. Alberts & R. Treisman: RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 17, 1350-1361 (1998)
216. Yan M., T. Dai, J. C. Deak, J. M. Kyriakis, L. I. Zon, J. R. Woodgett & D. J. Templeton: Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372, 798-800 (1994)
217. Minden A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson & M. Karin: Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266, 1719-1723 (1994)
218. Gupta S., D. Campbell, B. Derijard & R. J. Davis: Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 267, 389-393 (1995)
219. Russell M., C. A. Lange-Carter & G. L. Johnson: Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem 270, 11757-11760 (1995)
220. Adler V., M. R. Pincus, P. W. Brandtrauf & Z. Ronai: Complexes of p21(ras) with jun N-terminal kinase and jun proteins. Proc Natl Acad Sci USA 92, 10585-10589 (1995)
221. McCarthy S., M. Samuels, C. Pritchard, J. Abraham & M. McMahon: Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev 9, 1953-1964 (1995)
222. Finco T. S., J. K. Westwick, J. L. Norris, A. A. Beg, C. J. Der & A. S. Baldwin, Jr.: Oncogenic Ha-Ras-induced signaling activates NF-B transcriptional activity, which is required for cellular transformation. J Biol Chem 272, 24113-24116 (1997)
223. Adari H., D. R. Lowy, B. M. Willumsen, C. J. Der & F. McCormick: Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240, 518-521 (1988)
224. Yatani A., K. Okabe, P. Polakis, R. Halenbeck, F. McCormick & A. M. Brown: ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels. Cell 61, 769-776 (1990)
225. Martin G. A., A. Yatani, R. Clark, L. Conroy, P. Polakis, A. M. Brown & F. McCormick: GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currents. Science 225, 192-194 (1992)
226. Gibbs J. B., M. D. Schaber, T. L. Schofield & E. M. Scolnick: Xenopus oocyte germinal-vesicle breakdown induced by [Val12]Ras is inhibited by a cytosol-localized Ras mutant. Proc Natl Acad Sci USA 86, 6630-6634 (1989)
227. Duchesne M., F. Schweighoffer, F. Parker, F. Clerc, Y. Frobert, M. Nguy Thang & B. Tocque: Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling. Science 259, 525-528 (1993)
228. Pomerance M., M. N. Thang, B. Tocque & M. Pierre: The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation. Mol Cell Biol 16, 3179-3186 (1996)
229. Clark G. J., L. A. Quilliam, M. M. Hisaka & C. J. Der: Differential antagonism of Ras biological activity by catalytic and Src homology domains of Ras GTPase activation protein. Proc Natl Acad Sci USA 90, 4887-4891 (1993)
230. McGlade J., B. Brunkhorst, D. Anderson, G. Mbamalu, J. Settleman, S. Dedhar, M. Rozakis-Adcock, L. B. Chen & T. Pawson: The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. EMBO J 12, 3073-3081 (1993)
231. Kundra V., B. Anand-Apte, L. A. Feig & B. R. Zetter: The chemotactic response to PDGF-BB: evidence of a role for Ras. J Cell Biol 130, 725-731 (1995)
232. Pronk G. J., A. M. M. De Vries-Smits, C. Ellis & J. L. Bos: Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling. Oncogene 8, 2773-2780 (1993)
233. Parker F., F. Maurier, I. Delumeau, M. Duchesne, D. Faucher, L. Debussche, A. Dugue, F. Schweighoffer & B. Tocque: A Ras-GTPase-activating protein SH3-domain-binding protein. Mol Cell Biol 16, 2561-2569 (1996)
234. Johnson M. R., J. E. DeClue, S. Felzman, W. C. Vass, G. Xu, R. White & D. R. Lowy: Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 14, 641-645 (1994)
235. Xu G. F., B. Lin, K. Tanaka, D. Dunn, D. Wood, R. Gesteland, R. White, R. Weiss & F. Tamanoi: The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63, 835-841 (1990)
236. Ballester R., T. Michaeli, K. Gerguson, H. P. Xu, F. McCormick & M. Wigler: Genetic analysis of mammalian GAP expressed in yeast. Cell 59, 681-686 (1989)
237. Li Y. & R. White: Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene. Cancer Res 56, 2872-2876 (1996)
238. Nur-E-Kamal M. S., M. Varga & H. Maruta: The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype. J Biol Chem 268, 22331-22337 (1993)
239. Heim R. A., L. Kammorgan, C. G. Binnie, D. D. Corns, M. C. Cayouette, R. A. Farber, A. S. Aylsworth, L. M. Silverman & M. C. Luce: Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4, 975-981 (1995)
240. Upadhyaya M., D. J. Shaw & P. S. Harper: Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. Human Mutat 4, 83-101 (1994)
241. Shen M. H., P. S. Harper & M. Upadhyaya: Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 33, 2-17 (1996)
242. Mangues R., T. Corral, S. Lu, W. F. Symmans, L. Liu & A. Pellicer: NF1 inactivation cooperates with N-Ras In vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity. Oncogene 16, in press (1998)
243. Diaz-Meco M. T., J. Lozano, M. M. Municio, E. Berra, S. Frutos, L. Sanz & J. Moscat: Evidence for the In vitro and In vivo interaction of Ras with protein kinase Cz. J Biol Chem 269, 31706-31710 (1994)
244. Diaz-Meco M. T., M. M. Municio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz & J. Moscat: The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86, 777-786 (1996)
245. Kuriyama M., N. Harada, S. Kuroda, T. Yamamoto, M. Nakafuku, A. Iwamatsu, D. Yamamoto, R. Prasad, C. Croce, E. Canaani & K. Kaibuchi: Identification of AF-6 and Canoe as putative targets for Ras. J Biol Chem 271, 607-610 (1996)
246. Han L. & J. Colicelli: A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1. Mol Cell Biol 15, 1318-1323 (1995)
247. Vavvas D, X. Li, J. Avruch & X. F. Zhang: Identification of Nore1 as a potential Ras effector. J Biol Chem 273, 5439-5442 (1998)
248. Ponting C. P. & D. R. Benjamin: A novel family of Ras-binding domains. Trends Biochem Sci 21, 422-425 (1996)
249. Morgan D. O.: Principles of CDK regulation. Nature 374, 131-134 (1995)
250. Sherr C. J. & J. M. Roberts: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9, 1149-1163 (1995)
251. Mulcahy L. S., M. R. Smith & D. W. Stacey: Requirements for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313, 241-243 (1985)
252. Weinberg R. A.: The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995)
253. Brehm A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister & T. Kouzarides: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601 (1998)
254. Magnaghi-Jaulin L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche & A. Harel-Bellan: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605 (1998)
255. Filmus J., A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo & C. J. Conti: Induction of cyclin D1 overexpression by activated ras. Oncogene 9, 3627-3633 (1994)
256. Albanese C., H. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold & R. G. Pestell: Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270, 23589-23597 (1995)
257. Liu J. J., J. R. Chao, M. C. Jiang, S. Y. Ng, J. J. Y. Yen & H. F. Yang-Yen: Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol 15, 3654-3663 (1995)
258. Winston J. T., S. R. Coats, Y. Z. Wang & W. J. Pledger: Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12, 127-134 (1996)
259. Arber N. T., T. Sutter, M. Miyake, S. M. Kahn, V. S. Venkatraj, A. Sobrino, D. Warburton, P. R. Holt & I. B. Weinstein: Increased expression of cyclin D1 and the RB tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene 12, 1903-1908 (1996)
260. Aktas H., H. Cai & G. M. Cooper: Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 17, 3850-3857 (1997)
261. Kawada M., S. Yamagoe, Y. Murakami, K. Suzuki, S. Mizuno & Y. Uehara: Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15, 629-637 (1997)
262. Fan J. & J. R. Bertino: K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene 14, 2595-2607 (1997)
263. Lavoie J. N., G. LíAllemain, A. Brunet, R. M¸ller & J. Pouysségur: Cyclin D1 expression is regulated positively by the p42/p44 MAPK and negatively by the p38/HOG MAPK pathway. J Biol Chem 271, 20608-20616 (1996)
264. Cheng M., V. Sexl, C. J. Sherr & M. F. Roussel: Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 95, 1091-1096 (1998)
265. Kang J. S. & R. S Krauss: Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events. Mol Cell Biol 16, 3370-3380 (1996)
266. Peeper D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio & M. E. Ewen: Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386, 177-181 (1997)
267. Leone G., J. DeGregori, R. Sears, L. Jakoi & J. R. Nevins: Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387, 422-426 (1997)
268. Mittnacht S., H. Paterson, M. F. Olson & C. J. Marshall: Ras signalling is required for inactivation of the tumor suppressor pRb cell-cycle control protein. Curr Biol 3, 219-221 (1997)
269. Downward J.: Routine role for Ras. Curr Biol 7, R258-60 (1997)
270. Woods D., D. Parry, H. Cherwinski, E. Bosch, E. Lees & M. McMahon: Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17, 5598-5611 (1997)
271. Takuwa N. & Y. Takuwa: Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol 17, 5348-5358 (1997)
272. Pagano M.: Cell cycle regulation by the ubiquitin pathway. FASEB J 11, 1067-1075 (1997)
273. Serrano M., A. W. Lin, M. E. McCurrach, D. Beach & S. W. Lowe: Oncogenic ras provokes premature cell senescence associated with accumulaation of p53 and p16INK4a. Cell 88, 593-602 (1997)
274. Serrano M., E. GÛmez-Lahoz, R. A. DePinho, D. Beach & D. Bar-Sagi: Inhibition of Ras-induced proliferation and cellular transformation by p16 INK4. Science 267, 249-252 (1995)
275. Michieli P., W. Li, M. V. Lorenzi, T. Miki, R. Zakut, D. Givol & J. H. Pierce: Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH 3T3 cells. Oncogene 12, 775-784 (1996)
276. Lloyd A. C., F. Obermuller, S. Staddon, C. F. Barth, M. McMahon & H. Land: Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 11, 663-677 (1997)
277. Pumiglia K. M. & S. J. Decker: Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94, 448-452 (1997)
278. Sewing A., B. Wiseman, A. C. Lloyd & H. Land: High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 17, 5588-5597 (1997)
279. Pritchard C. A., M. L. Samuels, E. Bosch & M. McMahon: Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol 15, 6430-6442 (1995)
280. Land H., L. F. Parada & R. A. Weinberg: Cellular oncogenes and multistep carcinogenesis. Science 222, 771-778 (1983)
281. Land H., L. F. Parada & R. A. Weinberg: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983)
282. Ruley H. E.: Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304, 602-606 (1983)
283. Franza B. R. Jr., K. Maruyama, J. I. Garrels & H. E. Ruley: In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 44, 409-418 (1986)
284. Hirakawa T. & H. E. Ruley: Rescue of cells from ras oncogene-induced growth arrest by a second, complementary, oncogene. Proc Natl Acad Sci USA 85, 1519-1523 (1988)
285. Lloyd A. C.: Ras versus cyclin-dependent kinase inhibitors. Curr Opin Genet Dev 8, 43-48 (1998)
286. Missero C., C. F. Di, H. Kiyokawa, A. Koff & G. P. Dotto: The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 10, 3065-3075 (1996)
287. Lovec H., A. Sewing, F. C. Lucibello, R. Muller & T. Moroy: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9, 323-326 (1994)
288. Haas K., C. Johannes, C. Geisen, T. Schmidt, H. Karsunky, S. Blass-Kampmann, G. Obe & T. Moroy: Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4. Oncogene 15, 2615-2623 (1997)
289. Galaktionov K., A. K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda & D. Beach: CDC25 phosphatases as potential human oncogenes. Science 269, 1575-1577 (1995)
290. Johnson D. G. & R. Schneider-Broussard: Role of E2F in cell cycle control and cancer. Front Biosci 3, d447-458 (1998)
291. Land H., A. C. Chen, J. P. Morgenstern, L. F. Parada & R. A. Weinberg: Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol 6, 1917-1925 (1986)
292. Sinn E., W. Muller, P. Pattengale, I. Tepler, R. Wallace & P. Leder: Coexpression of MMTV/v-H-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes In vivo. Cell 49, 465-475 (1987)
293. Amati B., K. Alevizopoulos & J. Vlach: Myc and the cell cycle. Front Biosci 3, d250-268 (1998)
294. Joneson T. & D. Bar-Sagi: Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med 75, 587-593 (1997)
295. Treisman R.: Journey to the surface of the cell: Fos regulation and the SRE. EMBO J 14, 4905-4913 (1995)
296. Gille H., T. Strahl & P. E. Shaw: Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr Biol 5, 1191-1200 (1995)
297. Whitmarsh A. J., P. Shore, A. D. Sharrocks & R. J. Davis: Integration of MAP kinase signal transduction pathways at the serum response element. Science 269, 403-407 (1995)
298. Price M. A., F. H. Cruzalegui & R. Treisman: The p38 and ERK MAP kinase pathways co-operate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J 15, 6552-6563 (1996)
299. Weber J. D., W. Hu, S. C. Jefcoat Jr., D. M. Raben & J. J. Baldassare: Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27KIP1. J Biol Chem 272, 32966-32971 (1997)
300. Brennan P., J. W. Babbage, B. M. T. Burgering, B. Groner, K. Reif & D. A. Cantrell: Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7, 679-689 (1997)
301. Yang J.-J., J.-S. Kang & R. S. Krauss: Ras signals to the cell cycle machinery via multiple pathways to induce anchorage-independent growth. Mol Cell Biol 18, 2586-2595 (1998)
302. Genot E., S. Cleverley, S. Henning & D. Cantrell: Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J 15, 3923-3933 (1996)
303. Taylor S. J. & D. Shalloway: Cell cycle-dependent activation of Ras. Curr Biol 6, 1621-1627 (1996)
304. Tam S. W., J. W. Shay & M. Pagano: Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16INK4. Cancer Res 54, 5816-5820 (1994)